Доступ предоставлен для: Guest
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции
Critical Reviews™ in Therapeutic Drug Carrier Systems
Импакт фактор: 2.9 5-летний Импакт фактор: 3.72 SJR: 0.736 SNIP: 0.551 CiteScore™: 2.43

ISSN Печать: 0743-4863
ISSN Онлайн: 2162-660X

Том 36, 2019 Том 35, 2018 Том 34, 2017 Том 33, 2016 Том 32, 2015 Том 31, 2014 Том 30, 2013 Том 29, 2012 Том 28, 2011 Том 27, 2010 Том 26, 2009 Том 25, 2008 Том 24, 2007 Том 23, 2006 Том 22, 2005 Том 21, 2004 Том 20, 2003 Том 19, 2002 Том 18, 2001 Том 17, 2000 Том 16, 1999 Том 15, 1998 Том 14, 1997 Том 13, 1996 Том 12, 1995

Critical Reviews™ in Therapeutic Drug Carrier Systems

DOI: 10.1615/CritRevTherDrugCarrierSyst.v14.i2.30
34 pages

Lipidic Vector Systems for Gene Transfer

Robert J. Lee
Endocyte, Inc., 1291 E Cumberland Ave., West Lafayette, IN 47906
Leaf Huang
Laboratory of Drug Targeting, Department of Pharmacology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261

Краткое описание

Clinical application of gene therapy depends on the development of suitable gene transfer vehicles (vectors). Although generally not as efficient as viral vectors, nonviral systems such as lipidic vectors have the potential advantages of being less toxic, nonrestrictive in cargo DNA size, potentially targetable, and easy to produce in relatively large amounts. More important, lipidic vectors generally lack immunogenicity, allowing repeated in vivo transfection using the same vector. In this paper, we will attempt to summarize some of the recent advances in lipidic gene delivery vectors. Three types of lipidic gene transfer vectors are described: 1) DNA/cationic liposome complexes, 2) DNA encapsulated in neutral or anionic liposomes, and 3) liposome-en-trapped, polycation-condensed DNA (LPDI and LPDII). We review the various factors affecting vector structure and gene delivery efficiency, and we discuss the possible mechanisms of gene transfer and their implications in vector design.

Articles with similar content:

Gene Modulation for Treating Liver Fibrosis
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.24, 2007, issue 2
Kun Cheng, Ram I. Mahato
In Vivo Delivery Aspects of miRNA, shRNA and siRNA
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.29, 2012, issue 6
S. Trehan, N. I. Khatri, D. P. Baradia, Mohan N. Rathi, Ambikanandan Misra
Polymeric Micelles for Delivery of Poorly Water-Soluble Compounds
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.20, 2003, issue 5
Glen S. Kwon
Recent Developments of Biodegradable and Biocompatible Materials Based Micro/Nanoparticles for Delivering Macromolecular Therapeutics
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.26, 2009, issue 1
Guihua Huang, Yang Shi
Particulate Pulmonary Delivery Systems Containing Anti-Tuberculosis Agents
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.30, 2013, issue 4
Mradul Mohan, Imran Mohammad, Atul Kumar Agrawal, Sanketkumar M. Pandya, Amit Misra, Anuradha Gupta